MA53498A - Production de protéines recombinantes - Google Patents

Production de protéines recombinantes

Info

Publication number
MA53498A
MA53498A MA053498A MA53498A MA53498A MA 53498 A MA53498 A MA 53498A MA 053498 A MA053498 A MA 053498A MA 53498 A MA53498 A MA 53498A MA 53498 A MA53498 A MA 53498A
Authority
MA
Morocco
Prior art keywords
production
recombinant proteins
recombinant
proteins
Prior art date
Application number
MA053498A
Other languages
English (en)
Inventor
Sudeep Kumar
Dhananjay Sathe
Original Assignee
Unichem Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unichem Lab Ltd filed Critical Unichem Lab Ltd
Publication of MA53498A publication Critical patent/MA53498A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/178—Lectin superfamily, e.g. selectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42—Lectins, e.g. concanavalin, phytohaemagglutinin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA053498A 2018-08-31 2019-08-30 Production de protéines recombinantes MA53498A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN201821032765 2018-08-31

Publications (1)

Publication Number Publication Date
MA53498A true MA53498A (fr) 2021-07-07

Family

ID=68344911

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053498A MA53498A (fr) 2018-08-31 2019-08-30 Production de protéines recombinantes

Country Status (15)

Country Link
US (1) US11965003B2 (fr)
EP (1) EP3844183A2 (fr)
JP (1) JP7453213B2 (fr)
KR (1) KR102815461B1 (fr)
CN (1) CN113383015B (fr)
AU (1) AU2019330367B2 (fr)
BR (1) BR112021003628A2 (fr)
CA (1) CA3108842A1 (fr)
EA (1) EA202190240A1 (fr)
MA (1) MA53498A (fr)
MX (1) MX2021002295A (fr)
MY (1) MY209410A (fr)
SG (1) SG11202101391WA (fr)
WO (1) WO2020044296A2 (fr)
ZA (1) ZA202100859B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7515473B2 (ja) * 2018-11-19 2024-07-12 ユニケム ラボラトリーズ リミテッド 化学療法とリコンビナントｓ． ｒｏｌｆｓｉｉレクチンとの併用
CN114126584A (zh) * 2019-07-09 2022-03-01 联合化学实验室有限公司 重组蛋白质稳定制剂
CN115515619A (zh) * 2020-05-07 2022-12-23 联合化学实验室有限公司 抗癌蛋白
WO2022149068A1 (fr) * 2021-01-07 2022-07-14 Unichem Laboratories Ltd Protéine lectine pour le traitement et la prévention de maladies neurodégénératives
MX2024000195A (es) 2021-07-08 2024-03-11 Unichem Lab Ltd Proteinas recombinantes, composiciones y metodos para su estabilizacion.
EP4395806B1 (fr) * 2021-08-30 2025-10-22 Unichem Laboratories Ltd Compositions de protéines pour le traitement de la mucosite orale
CN117957023A (zh) 2021-10-01 2024-04-30 联合化学实验室有限公司 凝集素-药物偶联物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20241291T1 (hr) * 2009-02-18 2024-12-06 Unichem Laboratories Limited Rekombinantni lektini vezujućih stanica raka s antitumorskim djelovanjem i postupak pripreme
WO2014203261A2 (fr) * 2010-02-02 2014-12-24 Unichem Laboratories Ltd. Lectine recombinée et son procédé de préparation
US9500650B2 (en) * 2011-11-01 2016-11-22 National Institute Of Advanced Industrial Science And Technology Undifferentiated cell detection method and complex carbohydrate detection method
RU2016110800A (ru) * 2013-09-25 2017-10-30 Пронутриа Биосайенсис, Инк. Составы и композиции для поддержания и увеличения мышечной массы, силы и результативности, и способы их производства и использования
WO2015054507A1 (fr) * 2013-10-10 2015-04-16 Pronutria, Inc. Systèmes de production de polypeptides nutritifs et procédés de production et d'utilisation de ceux-ci

Also Published As

Publication number Publication date
CN113383015B (zh) 2023-06-20
BR112021003628A2 (pt) 2021-05-18
KR102815461B1 (ko) 2025-05-29
CN113383015A (zh) 2021-09-10
KR20210052449A (ko) 2021-05-10
CA3108842A1 (fr) 2020-03-05
JP7453213B2 (ja) 2024-03-19
US20210317171A1 (en) 2021-10-14
JP2021534776A (ja) 2021-12-16
MY209410A (en) 2025-07-08
EA202190240A1 (ru) 2021-08-09
WO2020044296A2 (fr) 2020-03-05
ZA202100859B (en) 2022-07-27
SG11202101391WA (en) 2021-03-30
EP3844183A2 (fr) 2021-07-07
US11965003B2 (en) 2024-04-23
AU2019330367B2 (en) 2024-11-21
WO2020044296A3 (fr) 2020-04-23
AU2019330367A1 (en) 2021-03-11
MX2021002295A (es) 2021-04-28

Similar Documents

Publication Publication Date Title
MA53498A (fr) Production de protéines recombinantes
EP3397764A4 (fr) Quantification numérique de protéines
DK3784047T3 (da) Gærproteiner
IL280278A (en) Fcrn antibody compositions
DK3746466T3 (da) Fremstilling af glucagonpeptider
MA56416A (fr) Détermination de la pureté de protéines multimériques
IL257986B (en) Expression of recombinant proteins in trichoplusia ni pupae
IL286745A (en) Continuous production of recombinant proteins
IL286475A (en) Methods for the manufacture of recombinant viral vectors
DK3737402T5 (da) Modificeret protein
EP3436049A4 (fr) Protéine 8 de type angiopoïétine (angptl8)
EP3377633C0 (fr) Production de protéines recombinantes
EP3697428A4 (fr) Peptides sécréteurs artificiels pour la production de protéines hétérologues
IL279782A (en) Methods of producing recombinant proteins
IL257887A (en) Expression of fc-containing proteins
EP3688037A4 (fr) Protéines de fusion immunomodulatrices
EP3464384A4 (fr) Construction de protéines de fusion
DK3833786T3 (da) Rekombinant nucleinsyrekonstrukt
EP3526234A4 (fr) Production de microcystine recombinante
IL311448A (en) Polypeptide
IL312470A (en) Novel proteins
EP3858868A4 (fr) Composition de polypeptide
IL287199A (en) Manufacture of disulfide bonded peptides
EP3680343A4 (fr) Procédé d'augmentation de la sécrétion de protéine recombinante
DK3183359T3 (da) Effektiv valg af rekombinante proteiner